Peroxisomal cholesterol biosynthesis and Smith-Lemli-Opitz syndrome

Biochemical and Biophysical Research Communications

Volumn 345, Issue 1, 2006, Pages 205-209

  Weinhofer, Isabelle ^a   Kunze, Markus ^a   Stangl, Herbert ^b   Porter, Forbes D ^c   Berger, Johannes ^a  

^a Medical University of Vienna   (Austria)

^b MEDICAL UNIVERSITY OF VIENNA   (Austria)

^c EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

Author keywords

Cholesterol synthesis; Peroxisome; Smith Lemli Opitz syndrome

Indexed keywords

7 DEHYDROCHOLESTEROL; ACETIC ACID; ACETYL COENZYME A; CARBON 14; CHOLESTEROL DERIVATIVE; ENZYME; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; MEVINOLIN;

ANIMAL CELL; ARTICLE; CHOLESTEROL SYNTHESIS; CONTROLLED STUDY; DISEASE SEVERITY; ENZYME ACTIVITY; ENZYME DEFICIENCY; FATTY ACID OXIDATION; FIBROBLAST; GENOTYPE; HUMAN; HUMAN CELL; NONHUMAN; PEROXISOME; PHENOTYPE; PHENOTYPIC VARIATION; PRIORITY JOURNAL; SMITH LEMLI OPITZ SYNDROME;

ACETYL COENZYME A; ANIMALS; CELLS, CULTURED; CERCOPITHECUS AETHIOPS; CHOLESTEROL; COS CELLS; FIBROBLASTS; HUMANS; OXIDOREDUCTASES ACTING ON CH-CH GROUP DONORS; PEROXISOMES; SMITH-LEMLI-OPITZ SYNDROME;

ANIMALIA;

EID: 33646393039     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2006.04.078     Document Type: Article

References (28)

1. Kovacs W.J., Olivier L.M., and Krisans S.K. Central role of peroxisomes in isoprenoid biosynthesis. Prog. Lipid Res. 41 (2002) 369-391
2. Keller G.A., Pazirandeh M., and Krisans S. 3-Hydroxy-3-methylglutaryl coenzyme A reductase localization in rat liver peroxisomes and microsomes of control and cholestyramine-treated animals: quantitative biochemical and immunoelectron microscopical analyses. J. Cell Biol. 103 (1986) 875-886
3. Stamellos K.D., Shackelford J.E., Tanaka R.D., and Krisans S.K. Mevalonate kinase is localized in rat liver peroxisomes. J. Biol. Chem. 267 (1992) 5560-5568
4. Krisans S.K., Ericsson J., Edwards P.A., and Keller G.A. Farnesyl-diphosphate synthase is localized in peroxisomes. J. Biol. Chem. 269 (1994) 14165-14169
5. Appelkvist E.L., and Kalen A. Biosynthesis of dolichol by rat liver peroxisomes. Eur. J. Biochem. 185 (1989) 503-509
6. Biardi L., and Krisans S.K. Compartmentalization of cholesterol biosynthesis. Conversion of mevalonate to farnesyl diphosphate occurs in the peroxisomes. J. Biol. Chem. 271 (1996) 1784-1788
7. Kovacs W.J., Shackelford J.E., Tape K.N., Richards M.J., Faust P.L., Fliesler S.J., and Krisans S.K. Disturbed cholesterol homeostasis in a peroxisome-deficient PEX2 knockout mouse model. Mol. Cell Biol. 24 (2004) 1-13
8. Hogenboom S., Tuyp J.J., Espeel M., Koster J., Wanders R.J., and Waterham H.R. Mevalonate kinase is a cytosolic enzyme in humans. J. Cell Sci. 117 (2004) 631-639
9. Hogenboom S., Tuyp J.J., Espeel M., Koster J., Wanders R.J., and Waterham H.R. Phosphomevalonate kinase is a cytosolic protein in humans. J. Lipid Res. 45 (2004) 697-705
10. Vanhorebeek I., Baes M., and Declercq P.E. Isoprenoid biosynthesis is not compromised in a Zellweger syndrome mouse model. Biochim. Biophys. Acta 1532 (2001) 28-36
11. Fitzky B.U., Witsch-Baumgartner M., Erdel M., Lee J.N., Paik Y.K., Glossmann H., Utermann G., and Moebius F.F. Mutations in the Delta7-sterol reductase gene in patients with the Smith-Lemli-Opitz syndrome. Proc. Natl. Acad. Sci. USA 95 (1998) 8181-8186
12. Wassif C.A., Maslen C., Kachilele-Linjewile S., Lin D., Linck L.M., Connor W.E., Steiner R.D., and Porter F.D. Mutations in the human sterol delta7-reductase gene at 11q12-13 cause Smith-Lemli-Opitz syndrome. Am. J. Hum. Genet. 63 (1998) 55-62
13. Waterham H.R., Wijburg F.A., Hennekam R.C., Vreken P., Poll-The B.T., Dorland L., Duran M., Jira P.E., Smeitink J.A., Wevers R.A., and Wanders R.J. Smith-Lemli-Opitz syndrome is caused by mutations in the 7-dehydrocholesterol reductase gene. Am. J. Hum. Genet. 63 (1998) 329-338
14. Correa-Cerro L.S., and Porter F.D. 3beta-hydroxysterol Delta7-reductase and the Smith-Lemli-Opitz syndrome. Mol. Genet. Metab. 84 (2005) 112-126
15. Krakowiak P.A., Nwokoro N.A., Wassif C.A., Battaile K.P., Nowaczyk M.J., Connor W.E., Maslen C., Steiner R.D., and Porter F.D. Mutation analysis and description of sixteen RSH/Smith-Lemli-Opitz syndrome patients: polymerase chain reaction-based assays to simplify genotyping. Am. J. Med. Genet. 94 (2000) 214-227
16. Jira P.E., Wanders R.J., Smeitink J.A., De Jong J., Wevers R.A., Oostheim W., Tuerlings J.H., Hennekam R.C., Sengers R.C., and Waterham H.R. Novel mutations in the 7-dehydrocholesterol reductase gene of 13 patients with Smith-Lemli-Opitz syndrome. Ann. Hum. Genet. 65 (2001) 229-236
17. Witsch-Baumgartner M., Gruber M., Kraft H.G., Rossi M., Clayton P., Giros M., Haas D., Kelley R.I., Krajewska-Walasek M., and Utermann G. Maternal apo E genotype is a modifier of the Smith-Lemli-Opitz syndrome. J. Med. Genet. 41 (2004) 577-584
18. Fitzky B.U., Glossmann H., Utermann G., and Moebius F.F. Molecular genetics of the Smith-Lemli-Opitz syndrome and postsqualene sterol metabolism. Curr. Opin. Lipidol. 10 (1999) 123-131
19. Wassif C.A., Zhu P., Kratz L., Krakowiak P.A., Battaile K.P., Weight F.F., Grinberg A., Steiner R.D., Nwokoro N.A., Kelley R.I., Stewart R.R., and Porter F.D. Biochemical, phenotypic and neurophysiological characterization of a genetic mouse model of RSH/Smith-Lemli-Opitz syndrome. Hum. Mol. Genet. 10 (2001) 555-564
20. Fitzky B.U., Moebius F.F., Asaoka H., Waage-Baudet H., Xu L., Xu G., Maeda N., Kluckman K., Hiller S., Yu H., Batta A.K., Shefer S., Chen T., Salen G., Sulik K., Simoni R.D., Ness G.C., Glossmann H., Patel S.B., and Tint G.S. 7-Dehydrocholesterol-dependent proteolysis of HMG-CoA reductase suppresses sterol biosynthesis in a mouse model of Smith-Lemli-Opitz/RSH syndrome. J. Clin. Invest. 108 (2001) 905-915
21. Yoshida S., and Wada Y. Transfer of maternal cholesterol to embryo and fetus in pregnant mice. J. Lipid Res. 46 (2005) 2168-2174
22. Hogenboom S., Wanders R.J., and Waterham H.R. Cholesterol biosynthesis is not defective in peroxisome biogenesis defective fibroblasts. Mol. Genet. Metab. 80 (2003) 290-295
23. Malle E., Oettl K., Sattler W., Hoefler G., and Kostner G.M. Cholesterol biosynthesis in dermal fibroblasts from patients with metabolic disorders of peroxisomal origin. Eur. J. Clin. Invest. 25 (1995) 59-67
24. Aboushadi N., and Krisans S.K. Analysis of isoprenoid biosynthesis in peroxisomal-deficient Pex2 CHO cell lines. J. Lipid Res. 39 (1998) 1781-1791
25. Correa-Cerro L.S., Wassif C.A., Waye J.S., Krakowiak P.A., Cozma D., Dobson N.R., Levin S.W., Anadiotis G., Steiner R.D., Krajewska-Walasek M., Nowaczyk M.J., and Porter F.D. DHCR7 nonsense mutations and characterisation of mRNA nonsense mediated decay in Smith-Lemli-Opitz syndrome. J. Med. Genet. 42 (2005) 350-357
26. Aboushadi N., Shackelford J.E., Jessani N., Gentile A., and Krisans S.K. Characterization of peroxisomal 3-hydroxy-3-methylglutaryl coenzyme A reductase in UT2 cells: sterol biosynthesis, phosphorylation, degradation, and statin inhibition. Biochemistry 39 (2000) 237-247
27. Hashimoto F., Ishikawa T., Hamada S., and Hayashi H. Effect of gemfibrozil on lipid biosynthesis from acetyl-CoA derived from peroxisomal beta-oxidation. Biochem. Pharmacol. 49 (1995) 1213-1221
28. Breitling R., and Krisans S.K. A second gene for peroxisomal HMG-CoA reductase? A genomic reassessment. J. Lipid Res. 43 (2002) 2031-2036